Device Review: Pulsante™ Sphenopalatine Ganglion Microstimulator

Nwazota, Nenna; Pyati, Srinivas; Fisher, Kyle; Roy, Lance

doi:10.2217/pmt-2018-0082

Cited by 2 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A chronically implantable neuromodulation device has been developed for acute SPG stimulation to abort the CH attacks on demand. 42 The neurostimulator device is implanted in the pterygopalatine fossa with the lead in contact with the SPG. The device does not contain a battery but is activated and powered by remote control using radiofrequency energy.…”

Section: Combined Occipital and Trigeminal Nerve Stimulationmentioning

confidence: 99%

“…The Pulsante ® (Autonomic Technologies Inc., Redwood City, CA, USA) device is under an investigational device exemption (IDE) study in the USA for approval by the FDA for the treatment of chronic CH; 42 it is Conformité Européenne (CE) marked in Europe for the acute treatment of CH. 46 There is increasing evidence that shows the effect of SGS on the autonomic and cerebral circulation, which potentially justifies a wider use of SGS for other chronic headaches and vascular diseases.…”

Section: Combined Occipital and Trigeminal Nerve Stimulationmentioning

confidence: 99%

See 1 more Smart Citation

Neuromodulation for Prevention and Treatment of Headache Disorders

Shirane¹,

Kim²,

Riveros³

et al. 2022

US Neurology

View full text Add to dashboard Cite

Neuromodulation is a treatment modality that can be used in the abortive and preventive treatment of migraine and other primary headache disorders. The basic concept of neurostimulation is to manipulate peripheral or central pain pathways with either magnetic or electrical impulses. Common neuromodulation techniques include occipital nerve stimulation, which is the oldest technique, and trigeminal nerve stimulation, combined occipital and trigeminal nerve stimulation, sphenopalatine ganglion stimulation, vagus nerve stimulation and transcranial magnetic stimulation, which were introduced soon after. The two newest modalities are remote electrical neuromodulation and caloric vestibular stimulation, the last of which is still in the experimental phases.

show abstract

Section: Combined Occipital and Trigeminal Nerve Stimulationmentioning

confidence: 99%

Section: Combined Occipital and Trigeminal Nerve Stimulationmentioning

confidence: 99%

Neuromodulation for Prevention and Treatment of Headache Disorders

Shirane¹,

Kim²,

Riveros³

et al. 2022

US Neurology

View full text Add to dashboard Cite

show abstract

“…6). Pain is less often reported in and around the eye and is more frequently reported in the following locations: maxillary (21,26) mandibular (27,22), temporal (29) (pre-and post-) auricular (30, 42), parietal (23), occipital ( 38), nuchal (35), wing of nose 7, regio-suprascapularis (36, 44), regio-interscapularis (37) regio-scapularis (41).…”

Section: Radiationmentioning

confidence: 99%

Phase Specific Pain Localization in Cluster Headache Patients.

Schröder¹,

Gaul²,

Drabik³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background and Objective:Applying local treatments like neuromodulation or injections for cluster headache, requires exact knowledge of the anatomical structures and pain topography. However studies with emphasis on exact pain localization are rare although local treatments are increasingly used for patients in whom systemic pharmacotherapy is ineffective or contraindicated. Here, survey results with emphasis on exact pain location in cluster headache attacks for onset of pain, peak pain and radiation of pain, are presented. Methods: Data from 631 respondents were collected for 23 months using an online survey composed of 117 questions on pain location, epidemiology, and clinical features. 5260 datapoints on 44 pain locations were analyzed.Results: There is a periorbital concentration of pain during onset and peak phases of attacks. Pain locations outside the periorbital region were reported more frequently during radiation when compared to the onset and peak of attacks. Dorsal (occipital/nuchal) pain is more frequent during onset and radiation compared to peak: onset pain (13%) vs. peak pain (6%), p < 0,001. Pain radiation (22%) vs. peak pain (6%), p < 0,001. There is no significant difference in dorsal pain frequencies for pain radiation (22%) vs. onset (13%), p = 0,552. Furthermore, single pain spots differ significantly in frequency during the three attack phases.Conclusions: Analysis of the pain location data shows phase specific frequencies and distributions of pain location during the three stages of a cluster headache attack. Single pain spots differ significantly in frequency during the three attack phases. Dorsal pain is more frequent during onset and radiation, compared to peak. Extra-orbital pain locations are more frequent during pain radiation. These findings will help to better understand cluster headache and might help to identify further target structures for local treatments.

show abstract

Device Review: Pulsante™ Sphenopalatine Ganglion Microstimulator

Cited by 2 publications

References 21 publications

Neuromodulation for Prevention and Treatment of Headache Disorders

Neuromodulation for Prevention and Treatment of Headache Disorders

Phase Specific Pain Localization in Cluster Headache Patients.

Contact Info

Product

Resources

About